Delivery Order SPE2DB22D1106-SPE2DB24FECF8
- Not listed
- The Defense Logistics Agency (DLA) Troop Support Medical has awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a firm fixed price delivery order contract valued at $7,905.56 to provide OFEV 150 MG CAPSULE 60S pharmaceuticals. The contract has a period of performance through February 20, 2024. Amerisourcebergen Drug Corp, a for-profit organization, is the prime contractor and no set-aside designation was used for this award. This delivery order contract is part...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The $7,905.56 contract is for the delivery of OFEV 150 MG CAPSULE 60S, a specialty pharmaceutical product, with a performance period through April 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA to...
- The Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the provision of OFEV 150 MG capsules. This $7,905.56 firm fixed price contract has an ultimate completion date of April 11, 2024. AmerisourceBergen Drug Corp is the prime contractor and this award is associated with a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 that was awarded solely to...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $7,905.56 to Amerisourcebergen Drug Corp, a subsidiary of the Amerisourcebergen Corporation, for the supply of OFEV 150 mg capsules. This contract has a period of performance through March 13, 2024. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) awarded by DLA with a potential value of $999,999,999.00 and a performance period through December 31, 2025....
- The Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract valued at $7,905.56 to AmerisourceBergen Drug Corp, a wholly-owned subsidiary of the parent company Cencora, Inc. This contract is for the provision of OFEV 150 MG CAPSULE 60S, a specialty pharmaceutical product, with a performance period extending through March 21, 2024. The contract is not set aside under any specific socioeconomic program. AmerisourceBergen Drug Corp is the prime contractor on this...
- The U.S. Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of OFEV 100 MG CAPSULE 60S pharmaceutical products. The contract, valued at $15,831.70, has a completion date of March 13, 2024. Amerisourcebergen Drug Corp serves as the prime contractor and is a for-profit organization. The contract is not designated as a set-aside....
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has been awarded a firm fixed price delivery order contract by the Defense Logistics Agency (DLA) to supply OFEV 150 MG CAPSULE 60S, a pharmaceutical product, with a potential value of $7,905.56. The contract has a performance period through March 19, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA Troop Support Medical as the primary vehicle for delivering pharmaceutical products...
- This federal contract award is for the delivery of OFEV 150 MG CAPSULE 60S pharmaceutical products to the Defense Logistics Agency (DLA), a defense agency. The $8,590.58 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of April 7, 2025 and was awarded on March 17, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has been awarded a firm fixed price delivery order contract by the Defense Logistics Agency (DLA) Troop Support Medical for the supply of OFEV 150 MG CAPSULE 60S, a pharmaceutical product. The contract has a potential value of $7,905.56 and a completion date of March 1, 2024. This delivery order is issued under an indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp, which has a total potential value of...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,590.58, is a delivery order for the supply of OFEV 150 MG CAPSULE 60S, a pharmaceutical product. The contract has an ultimate completion date of April 14, 2025 and is a firm-fixed-price contract. AmerisourceBergen Drug Corp is the prime contractor, and there is no set-aside designation for this...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB24FECF8Delivery Order
This contract award from the Defense Logistics Agency (DLA) is a firm fixed price delivery order for OFEV 150 MG CAPSULE 60S valued at $15,811.12. The prime contractor is Amerisourcebergen Drug Corp, a for-profit subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The contract has a completion date of March 20, 2024 and was awarded on February 28, 2024. This award is not associated with any set-aside program. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA Troop Support Medical with a potential value of up to $999,999,999.00 through December 31, 2025. This IDC serves as the primary vehicle for Amerisourcebergen to provide pharmaceuticals and medical supplies to support Department of Defense military treatment programs and facilities worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $15.8k | 2/28/24 |